Brief: Trisalus Life Sciences Declares CMS Reimbursement For Trinav Infusion System
14/12/2023 12:37
Dec 14 (Reuters) - TriSalus Life Sciences Inc TLSI.O :
* TRISALUS LIFE SCIENCES INC - CMS REIMBURSEMENT FOR TRINAV®
INFUSION SYSTEM
Source text for Eikon: ID:nBw5YXz2Va
Further company coverage: TLSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TriSalus Life Sciences
See all newsTriSalus jumps after FDA clears liver treatment device
Brief: Trisalus Life Sciences Receives FDA Clearance For Trinav Advance
TriSalus Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
TriSalus Life Sciences Q2 revenue beats estimates
TriSalus Life Sciences Inc expected to post a loss of 15 cents a share - Earnings Preview